Skip to main content
. 2013 Sep 30;8(9):e75759. doi: 10.1371/journal.pone.0075759

Figure 2. Levels of serum VEGF and sFlt-1 in RSA patients and normal pregnancy women.

Figure 2

(A) The levels of sFlt-1 in the RSA group were significantly higher than in the control group (p<0.0001). (B) The levels of VEGF in the RSA group were significantly higher than in the control group (p<0.0001). (C) The ratio of sFlt-1/VEGF in serum.